Assessing survival in recurrent or metastatic head and neck cancer patients after radiotherapy with/without targeted molecular therapy: A concise systematic review.
Researchers reviewed 14 studies involving over 26,000 patients to compare radiotherapy approaches for recurrent or metastatic head and neck cancer, finding that curative radiotherapy and combination treatments with immunotherapy produced the best survival outcomes, while palliative approaches effectively relieved symptoms with low toxicity.
A plain-English summary of the study's own findings — we don't add our own claims or interpretation. Read the full paper for the complete methods and results, and apply your own clinical judgement.
Read the full study at the sourceRelated CPD from Vital Pulp
Managing the Pregnant Dental Patient
Confident, evidence-based dental care from the first trimester to the postpartum period
The Recall — the month's most significant new dental research, summarised. Free.
Browse The Recall